资讯
The FDA wants to pull its approval of a drug. It’s not so easy.
📋总体概括
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
⚡关键信息
- ▸The regulator says Tavneos was approved on the basis of mani
📰 相关资讯（与本文相关的其他资讯）
本文由本站自动聚合，以下为原始来源：前往 Ars Technica 阅读全文 →